文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

英国住院后长新冠的炎症特征及其与1年恢复的关联:一项前瞻性观察研究

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
PubMed 文献 · Lancet Respir Med · 2022-04-23
一句话结论住院后1年多数患者未完全康复,女性、肥胖和有创机械通气与完全康复可能性低相关,全身炎症和肥胖是潜在可治疗特征。

PHOSP-COVID前瞻性纵向队列研究纳入英国≥18岁COVID-19出院成人,评估出院后5个月和1年的恢复情况。807例完成5个月和1年随访,1年时仅28.9%报告完全康复,与5个月时25.5%相比无变化。女性(OR 0.68)、肥胖(OR 0.50)和有创机械通气(OR 0.42)与1年时完全康复可能性低相关。聚类分析确认4个恢复集群,非常严重和中度伴认知障碍集群IL-6等炎症介质升高。作者认为全身炎症和肥胖是潜在可治疗特征,需进一步临床试验研究。

要点

  • 出院后1年仅28.9%(232/804)报告完全康复,与5个月时25.5%(501/1965)相比无变化。
  • 女性(OR 0.68 [95%CI 0.46-0.99])、肥胖(OR 0.50 [0.34-0.74])和有创机械通气(OR 0.42 [0.23-0.76])与1年时完全康复可能性低相关。
  • 聚类分析(n=1636)确认4个集群:非常严重、严重、中度伴认知障碍和轻度,反映5个月时躯体健康、心理健康和认知障碍的严重程度。
  • 非常严重和中度伴认知障碍集群较轻度集群组织损伤和修复的炎症介质升高,包括IL-6浓度(n=626参与者)。
  • EQ-5D-5L效用指数中位数从COVID-19前0.88(IQR 0.74-1.00)降至5个月0.74(0.64-0.88)和1年0.75(0.62-0.88),全队列和各集群所有结局指标1年改善甚微。

适用人群与场景

  • 英国≥18岁因COVID-19出院后成人,纳入PHOSP-COVID前瞻性纵向队列研究。

研究设计与关键结果

  • 研究类型为前瞻性纵向队列研究,2320例参与者于2020年3月7日至2021年4月18日期间出院,出院后5个月评估,807例(32.7%)完成5个月和1年随访。
  • 807例中女性279例(35.6%),男性505例(64.4%),平均年龄58.7岁(SD 12.5),224例(27.8%)曾接受有创机械通气(WHO分级7-9)。
  • 1年时报告完全康复的比例为28.9%(232/804),5个月时为25.5%(501/1965),两者无变化。
  • 1年时完全康复可能性低的相关因素:女性(OR 0.68 [95%CI 0.46-0.99])、肥胖(OR 0.50 [0.34-0.74])、有创机械通气(OR 0.42 [0.23-0.76])。
  • 聚类分析(n=1636)确认4个集群:非常严重、严重、中度伴认知障碍和轻度,与5个月时躯体健康、心理健康和认知障碍严重程度相关。
  • 非常严重集群和中度伴认知障碍集群较轻度集群组织损伤和修复的炎症介质升高,包括IL-6浓度在两组比较中均升高(n=626参与者)。
  • EQ-5D-5L效用指数中位数:COVID-19前(回顾性评估)0.88(IQR 0.74-1.00),5个月0.74(0.64-0.88),1年0.75(0.62-0.88);全队列和各集群所有结局指标1年改善甚微。

证据类型、等级与局限

  • 证据类型:前瞻性纵向队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为全身炎症和肥胖是潜在可治疗特征,需进一步临床试验研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for COVID-19, identify factors associated with patient-perceived recovery, and identify potential therapeutic targets by describing the underlying inflammatory profiles of the previously described recovery clusters at 5 months after hospital discharge.

METHODS: The Post-hospitalisation COVID-19 study (PHOSP-COVID) is a prospective, longitudinal cohort study recruiting adults (aged ≥18 years) discharged from hospital with COVID-19 across the UK. Recovery was assessed using patient-reported outcome measures, physical performance, and organ function at 5 months and 1 year after hospital discharge, and stratified by both patient-perceived recovery and recovery cluster. Hierarchical logistic regression modelling was performed for patient-perceived recovery at 1 year. Cluster analysis was done using the clustering large applications k-medoids approach using clinical outcomes at 5 months. Inflammatory protein profiling was analysed from plasma at the 5-month visit. This study is registered on the ISRCTN Registry, ISRCTN10980107, and recruitment is ongoing.

FINDINGS: 2320 participants discharged from hospital between March 7, 2020, and April 18, 2021, were assessed at 5 months after discharge and 807 (32·7%) participants completed both the 5-month and 1-year visits. 279 (35·6%) of these 807 patients were women and 505 (64·4%) were men, with a mean age of 58·7 (SD 12·5) years, and 224 (27·8%) had received invasive mechanical ventilation (WHO class 7-9). The proportion of patients reporting full recovery was unchanged between 5 months (501 [25·5%] of 1965) and 1 year (232 [28·9%] of 804). Factors associated with being less likely to report full recovery at 1 year were female sex (odds ratio 0·68 [95% CI 0·46-0·99]), obesity (0·50 [0·34-0·74]) and invasive mechanical ventilation (0·42 [0·23-0·76]). Cluster analysis (n=1636) corroborated the previously reported four clusters: very severe, severe, moderate with cognitive impairment, and mild, relating to the severity of physical health, mental health, and cognitive impairment at 5 months. We found increased inflammatory mediators of tissue damage and repair in both the very severe and the moderate with cognitive impairment clusters compared with the mild cluster, including IL-6 concentration, which was increased in both comparisons (n=626 participants). We found a substantial deficit in median EQ-5D-5L utility index from before COVID-19 (retrospective assessment; 0·88 [IQR 0·74-1·00]), at 5 months (0·74 [0·64-0·88]) to 1 year (0·75 [0·62-0·88]), with minimal improvements across all outcome measures at 1 year after discharge in the whole cohort and within each of the four clusters.

INTERPRETATION: The sequelae of a hospital admission with COVID-19 were substantial 1 year after discharge across a range of health domains, with the minority in our cohort feeling fully recovered. Patient-perceived health-related quality of life was reduced at 1 year compared with before hospital admission. Systematic inflammation and obesity are potential treatable traits that warrant further investigation in clinical trials.

FUNDING: UK Research and Innovation and National Institute for Health Research.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022. PMID: 35472304. doi:10.1016/S2213-2600(22)00127-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。